AT276756T - USE OF HEREGULIN AS AN EPITHELIAL CELL GROWTH FACTOR

23 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims
Document	Office	Kind	Date
2059898	United States of America	A	1998-02-04
9902390	United States of America	W	1999-02-03

Family members, oldest first
Document	Office	Kind
CA2318857A1	Canada	A1	1999-08-12
WO9939729A2	World Intellectual Property Organization (WIPO)	A2	1999-08-12
AU2581599A	Australia	A	1999-08-23
WO9939729A3	World Intellectual Property Organization (WIPO)	A3	1999-10-14
EP1053009A2	European Patent Office (EPO)	A2	2000-11-22
JP2002509076A	Japan	A	2002-03-26
US2002042087A1	United States of America	A1	2002-04-11
EP1053009B1	European Patent Office (EPO)	B1	2004-09-22
AT276756TThis record	Austria	T	2004-10-15
ATE276756T1	Austria	T1	2004-10-15
DE69920405D1	Germany	D1	2004-10-28
EP1510579A2	European Patent Office (EPO)	A2	2005-03-02
ES2229679T3	Spain	T3	2005-04-16
EP1510579A3	European Patent Office (EPO)	A3	2005-05-11
DE69920405T2	Germany	T2	2006-01-05
EP1510579B1	European Patent Office (EPO)	B1	2009-08-05
AT438720T	Austria	T	2009-08-15
ATE438720T1	Austria	T1	2009-08-15
DE69941228D1	Germany	D1	2009-09-17
ES2329467T3	Spain	T3	2009-11-26
DK1510579T3	Denmark	T3	2009-11-30
JP4485051B2	Japan	B2	2010-06-16
CA2318857C	Canada	C	2013-09-24

1 legal event, as the office reported them to INPADOC

Legal events, newest first
	Event	Code
2005-03-15	Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER	RER

CPC, 7: C07K16/22
A61K38/00
A61P11/00
C07K14/4756
A61P43/00
C07K2319/30
C12N2810/40
Filled: the office’s first classification
IPC, 13: A61K35 12
A61K38 00
A61K38 17
A61K38 18
A61K39 395
A61P11 00
A61P43 00
C07K14 475
C07K14 485
C07K16 22
C12N15 09
C12N15 12
C12P21 08

Use of heregulin as an epithelial cell growth factor